{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T20:54:16Z","timestamp":1794171256596,"version":"4.8.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.rdc.2009.10.007","type":"journal-article","created":{"date-parts":[[2009,12,4]],"date-time":"2009-12-04T04:54:28Z","timestamp":1259902468000},"page":"731-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Laboratory Tests to Assess Patients with Rheumatoid Arthritis: Advantages and Limitations"],"prefix":"10.1016","volume":"35","author":[{"given":"Theodore","family":"Pincus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuulikki","family":"Sokka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2009.10.007_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1126\/science.847460","article-title":"The need for a new medical model: a challenge for biomedicine","volume":"196","author":"Engel","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.rdc.2009.10.007_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1699-0463.1940.tb01475.x","article-title":"On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles","volume":"17","author":"Waaler","year":"1940","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.rdc.2009.10.007_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3181\/00379727-68-16375","article-title":"Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis","volume":"68","author":"Rose","year":"1948","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.rdc.2009.10.007_bib4","first-page":"25","article-title":"Presentation of two bone marrow elements: the tart cell and L.E. cell","volume":"23","author":"Hargraves","year":"1948","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rdc.2009.10.007_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2009.10.007_bib6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","article-title":"Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2009.10.007_bib7","first-page":"S69","article-title":"The use of second generation anti-CCP antibody (anti-CCP2) testing in rheumatoid arthritis\u2014a systematic review","volume":"23","author":"Riedemann","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2009.10.007_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2009.10.007_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2009.10.007_bib10","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3899\/jrheum.080770","article-title":"Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%\u201345% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States","volume":"36","author":"Sokka","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2009.10.007_bib11","first-page":"1138","article-title":"Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or American College of Rheumatology criteria for remission","volume":"30","author":"Sokka","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2009.10.007_bib12","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/art.1780241012","article-title":"Preliminary criteria for clinical remission in rheumatoid arthritis","volume":"24","author":"Pinals","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2009.10.007_bib13","first-page":"1227","article-title":"The clinical and research significance of the erythrocyte sedimentation rate","volume":"21","author":"Wolfe","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2009.10.007_bib14","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3899\/jrheum.081255","article-title":"Declines in erythrocyte sedimentation rates in patients with rheumatoid arthritis over the second half of the 20th century","volume":"36","author":"Abelson","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2009.10.007_bib15","first-page":"1817","article-title":"The level of inflammation in rheumatoid arthritis is determined early and remains stable over the long-term course of the illness","volume":"28","author":"Wolfe","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2009.10.007_bib16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0095-4543(21)00432-2","article-title":"A pragmatic approach to cost-effective use of laboratory tests and imaging procedures in patients with musculoskeletal symptoms","volume":"20","author":"Pincus","year":"1993","journal-title":"Prim Care"},{"key":"10.1016\/j.rdc.2009.10.007_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"10.1016\/j.rdc.2009.10.007_bib18","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.rdc.2009.10.007_bib19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0895-4356(93)90128-N","article-title":"Musculoskeletal disorders as determinants of disability in Finns aged 30 years or more","volume":"46","author":"M\u00e4kel\u00e4","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.rdc.2009.10.007_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2009.10.007_bib21","first-page":"710","article-title":"The prevalence of chronic widespread pain in the general population","volume":"20","author":"Croft","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2009.10.007_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X09000763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X09000763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:08:45Z","timestamp":1760180925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X09000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0889857X09000763"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2009.10.007","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laboratory Tests to Assess Patients with Rheumatoid Arthritis: Advantages and Limitations","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2009.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}